Fairly impressive actually. Valuation still seems VERY reasonable at 1.3x BV. Buybacks slowed, but profitability at insurance improved. BHE is growing rapidly. Interesting to see a sale of ~$3B in equities during the quarter. Frankly, the results were stronger then expected IMHO. Still reading through 10Q.